Evosep ApS: Financial statements 2022
CVR: 37510068
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Evosep ApS (CVR 37510068) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 53,509,833 and a net result of DKK -79,619,456 compared with DKK 16,675,475 the year before. That is an increase of 45% compared with the year before. Equity in the 2022 report amounted to DKK -34,405,880. The company had 20 employees in the financial year.
- Gross Profit
- DKK 53,509,833
- Profit/Loss
- DKK -79,619,456
- Equity
- DKK -34,405,880
- Total Assets
- DKK 112,239,535
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 53.5 mio. | -79.6 mio. | -34.4 mio. | 20 |
| 2021 | - | 36.9 mio. | 16.7 mio. | 45.2 mio. | 20 |
| 2020 | - | 21.6 mio. | 6.2 mio. | 28.5 mio. | 15 |
| 2019 | - | 9 mio. | -141 t. | 22.4 mio. | - |
| 2018 | - | 2.5 mio. | -5 mio. | 22.5 mio. | - |
Official annual report
Keep an eye on Evosep ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Evosep ApS has published its annual report for 2021. Gross profit came to DKK 36,908,323, and the net result was DKK 16,675,475.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The board consists of Stefan Karl Dieter Wolf (chair), Jens Bornhøft Christensen and Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees (2018). In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity in the 2025 report amounted to DKK 154,548,000.